舒泰神跌2.02%，成交额7.37亿元，主力资金净流出4282.25万元

Core Viewpoint - The stock of Shuyou Shen experienced a decline of 2.02% on November 5, with a trading price of 37.28 CNY per share and a total market capitalization of 17.81 billion CNY. The company has seen significant fluctuations in its stock price throughout the year, with a year-to-date increase of 403.10% but a recent decline over the past 60 days of 25.56% [1]. Company Overview - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. was established on August 16, 2002, and went public on April 15, 2011. The company primarily engages in the research, production, and sales of biological products and some chemical drugs. Its main revenue sources include: 59.17% from injectable nerve growth factor (Sutai), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1][2]. Financial Performance - For the period from January to September 2025, Shuyou Shen reported an operating income of 181 million CNY, representing a year-on-year decrease of 30.82%. The net profit attributable to the parent company was -30.69 million CNY, a decline of 227.71% compared to the previous year [2][3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Shuyou Shen increased to 46,500, a rise of 46.97%. The average number of circulating shares per person decreased by 31.98% to 9,745 shares [2]. Dividend Distribution - Since its A-share listing, Shuyou Shen has distributed a total of 771 million CNY in dividends. However, there have been no dividend distributions in the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of September 30, 2025, Xingshan He Run Mixed A (163406) is the third-largest shareholder with 12.27 million shares, a decrease of 3.45 million shares from the previous period. Xingshan He Yi Mixed A (163417) is the fifth-largest with 9.34 million shares, an increase of 3.39 million shares. E Fund Healthcare Industry Mixed A (110023) remains the eighth-largest shareholder with 5.84 million shares unchanged from the previous period [3].